Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3) (C-Term) Peptide

LILRB3 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5511234

Quick Overview for Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3) (C-Term) Peptide (ABIN5511234)

Target

LILRB3 (Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3))

Origin

Human

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    C-Term

    Sequence

    LFLLLFLLLR RQRHSKHRTS DQRKTDFQRP AGAAETEPKD RGLLRRSSPA

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-LIRB3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    LILRB3 (Leukocyte Immunoglobulin-Like Receptor B3 (LILRB3))

    Background

    LIRB3 may act as receptor for class I MHC antigens. It becomes activated upon coligation of LILRB3 and immune receptors, such as FCGR2B and the B-cell receptor. Down-regulates antigen-induced B- cell activation by recruiting phosphatases to its immunoreceptor tyrosine-based inhibitor motifs (ITIM).

    Alias Symbols: LILRB3,ILT5, LIR3,

    Protein Size: 631

    Gene ID

    102725035

    NCBI Accession

    XP_006726377

    UniProt

    O75022
You are here:
Chat with us!